title: Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction.
authors.forename: Powell
authors.initials: P
authors.lastname: Jose
authors.forename: Charles
authors.initials: C
authors.lastname: Tomson
authors.forename: Hicham
authors.initials: H
authors.lastname: Skali
authors.forename: Jean
authors.initials: J
authors.lastname: Rouleau
authors.forename: Eugene
authors.initials: E
authors.lastname: Braunwald
authors.forename: J Malcolm
authors.initials: JM
authors.lastname: Arnold
authors.forename: Thomas
authors.initials: T
authors.lastname: Cuddy
authors.forename: Bruce
authors.initials: B
authors.lastname: Sussex
authors.forename: Victoria
authors.initials: V
authors.lastname: Bernstein
authors.forename: Marc
authors.initials: M
authors.lastname: Pfeffer
authors.forename: Scott
authors.initials: S
authors.lastname: Solomon
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000652:urine*; D011507:Proteinuria / Q000150:complications* / Q000209:etiology; D018570:Risk Assessment
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors